Stefanie Meien

Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome

G. Rosenberger, K. Kutsche, Stefanie Meien, 2009, Human mutation.

Two novel cases further expand the phenotype of TOR1AIP1-associated nuclear envelopathies

B. Korf, D. Lessel, P. Nürnberg, 2020, Human Genetics.

Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break Repair

C. Bokemeyer, H. Huland, K. Rothkamm, 2020, Cancers.

A novel HRAS substitution (c.266C>G; p.S89C) resulting in decreased downstream signaling suggests a new dimension of RAS pathway dysregulation in human development

K. Gripp, G. Rosenberger, D. Stabley, 2012, American journal of medical genetics. Part A.

Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors

Nathanael D. Moore, D. Rader, E. V. Van Allen, 2019, JAMA oncology.